ADMA Biologics (ADMA) stock drops 14.7% as 3 executives sell shares

From Yahoo Finance: 2025-06-24 10:21:00

ADMA Biologics (ADMA) stock nose-dived by 14.7% week-on-week, closing at $17.74 on Friday, down from $20.81 on June 13. This drop followed three executives selling shares in the company, including President and CEO Adam Grossman, who sold 21,000 shares for $437,010 and acquired 15,000 shares for $81,000 on June 16.

The sales were part of a Rule 10b5-1 trading plan between Grossman and Fidelity Brokerage Services LLC. Chairman Steven Elms sold 425,621 shares for $9.3 million, and founder Jerrold Grossman sold 10,000 shares for $206,100. ADMA Biologics’ closing price on Friday marked the sixth consecutive day of decline.

While ADMA has investment potential, some AI stocks may offer higher returns with limited downside risk. Consider exploring other AI stocks for investment opportunities. This article was originally published on Insider Monkey with no disclosed affiliations.



Read more at Yahoo Finance: ADMA Biologics (ADMA) Drops 14.7% W/W as 3 Execs Unload Portfolios